Life sciences companies face significant disruption as the industry evolves its focus from product to value, driven by the requirement for real-world evidence and improved patient outcomes. Kantar helps you understand the market, commercialise your assets, and maximise value by delivering focused evidence and patient insights.
Helping patients stick with their medicationRead case study
Touchpoint optimisation for a pharmaceutical companyRead case study
Broadening a niche brand with patient co-creationRead case study
Powerful performance monitoring for a global pharma brandRead case study
Using behavioural change insights to overcome barriers to prescribingRead case study
Launching a pediatric rare disease drug in ChinaRead case study